EX-FILING FEES 2 d316212dexfilingfees.htm EX-FILING FEES EX-FILING FEES

Exhibit 107

Calculation of Filing Fee Tables

Form S-3

(Form Type)

Kura Oncology, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

 

                         
     Security
Type
  Security
Class
Title
  Fee
Calculation
or Carry
Forward
Rule
  Amount
Registered
  Proposed
Maximum
Offering
Price Per
Share
  Maximum
Aggregate
Offering
Price
  Fee
Rate
  Amount of
Registration
Fee
  Carry
Forward
Form
Type
  Carry
Forward
File
Number
  Carry
Forward
Initial
effective
date
  Filing Fee
Previously
Paid In
Connection
with Unsold
Securities to
be Carried
Forward
 
Newly Registered Securities
                         
Fees to Be
Paid
  Equity   Common Stock, par value $0.0001 per share   457(o) and 457(r)       $150,000,000   $92.70   $13,905          
                         
Fees Previously Paid                          
 
Carry Forward Securities
                         
Carry Forward Securities                        
                   
    Total Offering Amounts      $150,000,000     $13,905          
                   
    Total Fees Previously Paid                   
                   
    Total Fee Offsets                   
                   
    Net Fees Due                $13,905                

Table 2: Fee Offset Claims and Sources

 

                       
     Registrant or
Filer Name
  Form
or
Filing
Type
  File Number   Initial Filing
Date
  Filing Date   Fee Offset
Claimed
  Security Type
Associated with
Fee Offset
Claimed
  Security
Title
Associated
with Fee
Offset
Claimed
  Unsold
Securities
Associated
with Fee
Offset
Claimed
  Unsold
Aggregated
Offering Amount
Associated with
Fee Offset
Claimed
  Fee Paid
with Fee
Offset
Source
 
Rules 457(b) and 0-11(a)(2)
                       
Fee Offset Claims                        
                       
Fee Offset Sources                      
 
Rule 457(p)(1)
                       
Fee Offset Claims   Kura Oncology, Inc.   S-3   333-228172   11/5/2018     $10,260   Unallocated (Universal) Shelf   Common Stock, par value $0.0001 per share     $84,650,000    
                       
Fee Offset Sources   Kura Oncology, Inc.   S-3   333-228172   11/5/2018   11/5/2018                       $10,260

 

(1)

The registrant’s registration statement on Form S-3 (File No. 333-228172), filed with the Securities and Exchange Commission on November 5, 2018 and declared effective on November 11, 2018, expired on November 11, 2021.